Central Trust Company’s Repligen RGEN Stock Holding History

Central Trust Company’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.32K	Sell	17 -13	-43%	-$1.6K	﹤0.01%	1404
2026 Q1	$3.54K	Hold	30	–	–	﹤0.01%	1306
2025 Q4	$4.92K	Buy	30 +6	+25%	+$940	﹤0.01%	1229
2025 Q3	$3.21K	Hold	24	–	–	﹤0.01%	1248
2025 Q2	$2.99K	Hold	24	–	–	﹤0.01%	1271
2025 Q1	$3.05K	Hold	24	–	–	﹤0.01%	1275
2024 Q4	$3.46K	Hold	24	–	–	﹤0.01%	1253
2024 Q3	$3.57K	Hold	24	–	–	﹤0.01%	1200
2024 Q2	$3.03K	Hold	24	–	–	﹤0.01%	1235
2024 Q1	$4.42K	Hold	24	–	–	﹤0.01%	1184
2023 Q4	$4.32K	Hold	24	–	–	﹤0.01%	1182
2023 Q3	$3.82K	Buy	+24	New	+$3.92K	﹤0.01%	1176
2022 Q1	–	Sell	-101	Closed	-$27K	–	1461
2021 Q4	$27K	Hold	101	–	–	﹤0.01%	904
2021 Q3	$29K	Buy	101 +85	+531%	+$21.8K	﹤0.01%	853
2021 Q2	$3K	Sell	16 -1,359	-99%	-$264K	﹤0.01%	1124
2021 Q1	$267K	Sell	1,375 -122	-8%	-$25K	0.01%	468
2020 Q4	$287K	Sell	1,497 -15	-1%	-$2.73K	0.01%	437
2020 Q3	$223K	Buy	1,512 +1,460	+2,808%	+$209K	0.01%	441
2020 Q2	$6K	Hold	52	–	–	﹤0.01%	902
2020 Q1	$5K	Sell	52 -10	-16%	-$965	﹤0.01%	984
2019 Q4	$6K	Sell	62 -14	-18%	-$1.18K	﹤0.01%	1036
2019 Q3	$6K	Sell	76 -53	-41%	-$4.64K	﹤0.01%	1006
2019 Q2	$11K	Sell	129 -20	-13%	-$1.36K	﹤0.01%	902
2019 Q1	$9K	Buy	+149	New	+$8.57K	﹤0.01%	908
2018 Q1	–	Sell	-100	Closed	-$4K	–	1315
2017 Q4	$4K	Buy	+100	New	+$3.62K	﹤0.01%	1119

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Central Trust Company's RGEN Position: Q2 2026 in Review

Central Trust Company reduced its Repligen (RGEN) stake by 43% in Q2 2026, selling an estimated $1.6K and leaving 17 shares worth $2.32K. The position accounts for ﹤0.01% of the portfolio, ranked #1404.

Central Trust Company first reported a position in RGEN in Q4 2017 and has held it in 25 quarters since. The position peaked at $287K in Q4 2020. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

Central Trust Company held 17 shares of Repligen worth $2.32K as of Q2 2026.
Central Trust Company sold 13 Repligen shares in Q2 2026, an estimated $1.6K.
Repligen made up ﹤0.01% of Central Trust Company's portfolio in Q2 2026, its #1404 holding.
Central Trust Company first reported a position in Repligen in Q4 2017 and has held it in 25 quarters since.
Central Trust Company's Repligen position peaked at $287K in Q4 2020.
482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.